← Eichor
Condition: Deb Dystrophic Epidermolysis Bullosa Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Deb Dystrophic Epidermolysis Bullosa

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Phase N/A · 1 location(s) · Stanford University · NCT01019148
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
Phase 2 · 2 location(s) · Stanford University · NCT06731933
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
Phase N/A · 1 location(s) · Krystal Biotech, Inc. · NCT06563414
A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dys
Phase N/A · 4 location(s) · Abeona Therapeutics, Inc · NCT07700966
Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa
Phase 1/Phase 2 · 1 location(s) · Isfahan University of Medical Sciences · NCT07230223
A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
Phase 3 · 5 location(s) · Krystal Biotech, Inc. · NCT07016750
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
Phase 1/Phase 2 · 1 location(s) · M. Peter Marinkovich · NCT06834035
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
Phase 2 · 9 location(s) · Xinnate AB · NCT06594393
GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment
Phase 1/Phase 2 · 1 location(s) · CHU de Quebec-Universite Laval · NCT07193134
MSC EVs in Dystrophic Epidermolysis Bullosa
Phase 1/Phase 2 · 3 location(s) · Aegle Therapeutics · NCT04173650
Long-Term Follow-up Protocol
Phase N/A · 3 location(s) · Krystal Biotech, Inc. · NCT04917887
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo A
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06177353
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.